Arthur F. Ryan - Jan 3, 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Arthur F. Ryan
Stock symbol
REGN
Transactions as of
Jan 3, 2023
Transactions value $
-$72,629
Form type
4
Date filed
1/5/2023, 03:37 PM
Previous filing
Dec 2, 2022
Next filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale -$10.1K -14 -0.07% $721.48 19.3K Jan 3, 2023 Direct F1, F2
transaction REGN Common Stock Sale -$3.61K -5 -0.03% $722.59 19.3K Jan 3, 2023 Direct F1, F3
transaction REGN Common Stock Sale -$7.24K -10 -0.05% $723.52 19.3K Jan 3, 2023 Direct F1, F4
transaction REGN Common Stock Sale -$6.52K -9 -0.05% $724.52 19.2K Jan 3, 2023 Direct F1, F5
transaction REGN Common Stock Sale -$6.53K -9 -0.05% $725.63 19.2K Jan 3, 2023 Direct F1, F6
transaction REGN Common Stock Sale -$7.26K -10 -0.05% $726.34 19.2K Jan 3, 2023 Direct F1, F7
transaction REGN Common Stock Sale -$9.46K -13 -0.07% $727.59 19.2K Jan 3, 2023 Direct F1, F8
transaction REGN Common Stock Sale -$8.01K -11 -0.06% $728.34 19.2K Jan 3, 2023 Direct F1, F9
transaction REGN Common Stock Sale -$730 -1 -0.01% $729.92 19.2K Jan 3, 2023 Direct F1
transaction REGN Common Stock Sale -$2.92K -4 -0.02% $730.35 19.2K Jan 3, 2023 Direct F1, F10
transaction REGN Common Stock Sale -$8.78K -12 -0.06% $731.59 19.2K Jan 3, 2023 Direct F1, F11
transaction REGN Common Stock Sale -$1.46K -2 -0.01% $732.18 19.2K Jan 3, 2023 Direct F1, F12
transaction REGN Common Stock Award $0 +165 +0.86% $0.00 19.3K Jan 3, 2023 Direct F13

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Award $0 +1.93K $0.00 1.93K Jan 3, 2023 Common Stock 1.93K $725.89 Direct F14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 14 shares of Company stock on January 3, 2023 at prices ranging from $721.09 to $721.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price.
F3 Represents volume-weighted average price of sales of 5 shares of Company stock on January 3, 2023 at prices ranging from $722.01 to $722.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price.
F4 Represents volume-weighted average price of sales of 10 shares of Company stock on January 3, 2023 at prices ranging from $723.25 to $723.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price.
F5 Represents volume-weighted average price of sales of 9 shares of Company stock on January 3, 2023 at prices ranging from $724.05 to $724.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price.
F6 Represents volume-weighted average price of sales of 9 shares of Company stock on January 3, 2023 at prices ranging from $725.00 to $725.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price.
F7 Represents volume-weighted average price of sales of 10 shares of Company stock on January 3, 2023 at prices ranging from $726.00 to $726.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price.
F8 Represents volume-weighted average price of sales of 13 shares of Company stock on January 3, 2023 at prices ranging from $727.06 to $727.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price.
F9 Represents volume-weighted average price of sales of 11 shares of Company stock on January 3, 2023 at prices ranging from $728.02 to $728.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price.
F10 Represents volume-weighted average price of sales of 4 shares of Company stock on January 3, 2023 at prices ranging from $730.17 to $730.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price.
F11 Represents volume-weighted average price of sales of 12 shares of Company stock on January 3, 2023 at prices ranging from $731.03 to $731.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price.
F12 Represents volume-weighted average price of sales of 2 shares of Company stock on January 3, 2023 at prices ranging from $732.00 to $732.35. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 3, 2023 at each separate price.
F13 Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Company's common stock.
F14 On the date of the Company's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant.